Emergent Biosolutions
EBS
EBS
199 hedge funds and large institutions have $907M invested in Emergent Biosolutions in 2015 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 73 increasing their positions, 68 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
1% more call options, than puts
Call options by funds: $658K | Put options by funds: $654K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
12% less capital invested
Capital invested by funds: $1.02B → $907M (-$118M)
Holders
199
Holding in Top 10
1
Calls
$658K
Puts
$654K
Top Buyers
| 1 | +$5.88M | |
| 2 | +$5.86M | |
| 3 | +$5.56M | |
| 4 |
GT
Glenmede Trust
Philadelphia,
Pennsylvania
|
+$4.61M |
| 5 |
D.E. Shaw & Co
New York
|
+$3.25M |
Top Sellers
| 1 | -$11.3M | |
| 2 | -$3.95M | |
| 3 | -$3.58M | |
| 4 |
Goldman Sachs
New York
|
-$3.41M |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$2.49M |